Clinical Trial Update: The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study assessing how castration from androgen deprivation therapy affects zolpidem PK after a single dose in men with prostate cancer c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Zolpidem (zolpidem)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostatic Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2025-02-11